Sign In
Buy SVRA
$5.25
+0 (+0%)
At Close: Jun 03, 2026
Savara to Present at the Jefferies Healthcare Conference
08:05am, Friday, 02'nd Jun 2023
AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate i
Why Shares of Savara Jumped on Tuesday
12:32pm, Tuesday, 16'th May 2023
Savara is a clinical-stage pharmaceutical company with no revenue. The company expects a top-line readout on molgramostim in the second quarter of 2024.
Savara to Present at the Oppenheimer 33rd Annual Healthcare Conference
04:05pm, Monday, 06'th Mar 2023
AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at th
Why Shares of Savara Soared This Week
03:47pm, Friday, 27'th Jan 2023
The clinical-stage biopharmaceutical company focuses on therapies to treat rare respiratory diseases.
Savara to Present at H.C. Wainwright 24th Annual Global Investment Conference
08:05am, Thursday, 01'st Sep 2022
AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that Matt Pauls, Chair and CEO, Savara will
Zacks.com featured highlights include Savara, The LGL Group, and Harte Hanks
10:19am, Monday, 11'th Jul 2022 Zacks Investment Research
Savara, The LGL Group, and Harte Hanks are part of zacks Screen of the Week article.
3 Top Breakout Stocks to Add to Your Portfolio Now
11:10am, Friday, 08'th Jul 2022 Zacks Investment Research
Savara (SVRA), LGL Group (LGL) and Harte Hanks (HHS) have been selected as the breakout stocks for today.
3 Top Breakout Stocks to Add to Your Portfolio Now
08:33am, Friday, 08'th Jul 2022
Savara (SVRA), LGL Group (LGL) and Harte Hanks (HHS) have been selected as the breakout stocks for today.
Has Assertio (ASRT) Outpaced Other Medical Stocks This Year?
01:40pm, Friday, 17'th Jun 2022 Zacks Investment Research
Here is how Assertio (ASRT) and Savara Inc. (SVRA) have performed compared to their sector so far this year.
Savara to Present at Jefferies Healthcare Conference
04:05pm, Wednesday, 01'st Jun 2022
AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at th
After Golden Cross, Savara Inc. (SVRA)'s Technical Outlook is Bright
01:55pm, Monday, 23'rd May 2022 Zacks Investment Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
After Golden Cross, Savara Inc. (SVRA)'s Technical Outlook is Bright
11:18am, Monday, 23'rd May 2022
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
Savara to Present at Oppenheimer’s 32nd Annual Healthcare Conference
01:05pm, Wednesday, 09'th Mar 2022 Business Wire
AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at Oppenheimer’s 32nd Annual Healthcare Conference on March 16, 2022 at 3:20 pm ET. A live webcast of the presentation will be available on Savara’s website at www.savarapharma.com/investors/events-presentations/ and will be archived for 90 days. About Savara Savara is a clinical stage biopharmaceutical
Savara to Present at Oppenheimer's 32nd Annual Healthcare Conference
08:05am, Wednesday, 09'th Mar 2022
AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at Op
Savara to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
08:05am, Tuesday, 04'th Jan 2022
AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at th
